---
title: "Demystifying NT-proBNP as a Screening Marker for Underwriting Purposes "
date: 2017-11-01T12:20:47+0000
author: matt
draft: True
---
Since the early 2000s cardiac biomarkers have become the cornerstone for diagnosis, risk stratification and therapeutic decision in cardiovascular diseases, specifically NT-proBNP (congestive heart failure) and cardiac troponins (acute coronary syndromes).

[ Demystifying NT-proBNP as a Screening Marker for Underwriting Purposes ]( http://www.scorgloballifeamericas.com/en-us/knowledgecenter/nt-probnp-screening-marker-underwriting )
